Aurobindo Pharma Ltd

NSE: AUROPHARMA BSE: 524804

₹1497.80

(3.75%)

Sun, 21 Jun 2026, 05:17 am

MTF 5xInvest in Aurobindo Pharma Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)83812.58

PE Ratio24.82

Dividend0.28

Health Technology

Pharmaceuticals: Other

24.5K

Aurobindo Pharma News

Aurobindo Pharma promoter encumbrance status

Promoters of Aurobindo Pharma confirm no new encumbrances on shares as of March 31, 2026, beyond prior disclosures.

20 Jun 2026

companies

Aurobindo Pharma gets US FTC nod for Lannett buy

Aurobindo Pharma USA Inc secured US FTC approval to acquire 100% of Lannett Company LLC. The deal is set to close by June 30, 2026.

19 Jun 2026

companies

US FDA Tags Aurobindo's Eugia Unit-III as OAI

The US FDA has classified Aurobindo Pharma's Eugia Unit-III facility as Official Action Indicated (OAI) following an inspection that identified 11 findings.

12 Jun 2026

companies

Aurobindo Pharma to attend Goldman Sachs meet

Aurobindo Pharma officials will attend a Goldman Sachs investor meeting in Hyderabad on June 12, 2026. No unpublished price sensitive information will be discussed.

09 Jun 2026

companies

Aurobindo Pharma to attend UBS investor meet

Aurobindo Pharma officials will attend a virtual investor meeting hosted by UBS on June 10, 2026. No unpublished price sensitive information will be discussed.

05 Jun 2026

companies

Showing 1–5 of 136

Rows per page:

Market Current News

Anubhav Plast IPO subscribed 1.2x

Anubhav Plast IPO subscribed 1.2x overall. QIB subscribed 1.01x, Retail 1.18x, and Non-Institutional Buyers saw strong demand.

19 Jun 2026

ipo

Jio Platforms to Offer 270 Million New Shares in IPO

Jio Platforms, a subsidiary of Reliance Industries, plans to offer 270 million new shares in an upcoming India IPO, marking a significant capital market development.

19 Jun 2026

ipo

QMS MEDICAL ALLIED S LTD

QMS Medical migrates to NSE Mainboard

QMS Medical Allied Services migrated 1.93 crore shares to NSE Mainboard. FY26 revenue stood at ₹172.9 crore with EBITDA of ₹25.9 crore.

18 Jun 2026

ipo

NSE files ₹30,000 crore DRHP

NSE filed a DRHP for a ₹30,000 crore Offer for Sale, set to be India's largest IPO. Shares will list on BSE.

18 Jun 2026

ipo

Dhanwel Hybrid Seeds IPO analysis

Dhanwel Hybrid Seeds IPO opens Jun 24, 2026, to raise ₹19.20 crore. Revenue grew 110% to ₹74.59 crore in FY26, but operating cash flows remain negative.

18 Jun 2026

ipo

Showing 1–5 of 93902

Rows per page: